Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Receivables (2021 - 2025)

Cardio Diagnostics Holdings' Receivables history spans 4 years, with the latest figure at $11221.0 for Q3 2025.

  • For Q3 2025, Receivables fell 20.42% year-over-year to $11221.0; the TTM value through Sep 2025 reached $11221.0, down 20.42%, while the annual FY2024 figure was $18612.0, 275.24% up from the prior year.
  • Receivables for Q3 2025 was $11221.0 at Cardio Diagnostics Holdings, down from $12927.0 in the prior quarter.
  • Across five years, Receivables topped out at $18988.0 in Q1 2024 and bottomed at $350.0 in Q3 2023.
  • The 4-year median for Receivables is $9552.0 (2025), against an average of $9107.4.
  • The largest annual shift saw Receivables soared 3928.57% in 2024 before it plummeted 49.69% in 2025.
  • A 4-year view of Receivables shows it stood at $901.0 in 2021, then surged by 450.5% to $4960.0 in 2023, then skyrocketed by 275.24% to $18612.0 in 2024, then plummeted by 39.71% to $11221.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Receivables are $11221.0 (Q3 2025), $12927.0 (Q2 2025), and $9552.0 (Q1 2025).